Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilla Davids

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Microbiology|July 11, 2025
Antimycobacterial activity of the plectasin derivative NZ2114Camilla Davids, Komal Rao-Fransson, Nitya Krishnan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 8, 2025
Bioinspired mycobacterial lipid coating of porous particles for enhanced antimicrobial efficacyJesús E Campos Pacheco, Camilla Davids, Tetiana Yalovenko, et al.
Trends in Biotechnology|March 31, 2026
Engineered phage-derived lysins effectively kill mycobacterial pathogensAdel Abouhmad, Jana Kassaliete, Camilla Davids, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 13, 2024
Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosisJesús E Campos Pacheco, Tetiana Yalovenko, Azra Riaz, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Microbiology|July 11, 2025
Antimycobacterial activity of the plectasin derivative NZ2114Camilla Davids, Komal Rao-Fransson, Nitya Krishnan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 8, 2025
Bioinspired mycobacterial lipid coating of porous particles for enhanced antimicrobial efficacyJesús E Campos Pacheco, Camilla Davids, Tetiana Yalovenko, et al.
Trends in Biotechnology|March 31, 2026
Engineered phage-derived lysins effectively kill mycobacterial pathogensAdel Abouhmad, Jana Kassaliete, Camilla Davids, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 13, 2024
Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosisJesús E Campos Pacheco, Tetiana Yalovenko, Azra Riaz, et al.
Pageof 1